Monument Capital Management Bristol Myers Squibb CO Transaction History

Monument Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $70,441 - $79,896	-1,072 Reduced 16.15%	5,567 $385,000
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $139,082 - $164,693	2,031 Added 44.08%	6,639 $0
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $151 - $89,288	-1,162 Reduced 20.14%	4,608 $328,000
Q2 2022 Jul 20, 2022	BUY	$72.62 - $79.98 $165,283 - $182,034	2,276 Added 65.14%	5,770 $444,000
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $214,811 - $257,577	3,494 New	3,494 $255,000
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $188,042 - $220,267	-3,178 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $196,749 - $214,260	3,178 New	3,178 $212,000
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $1,462 - $1,896	-30 Closed	0 $0
Q3 2018 Oct 11, 2018	BUY	$55.19 - $62.25 $1,655 - $1,867	30 New	30 $2,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

Stay updated on Monument Capital Management with notifications on news.